Atlas Trials

Dose-Escalating Multiple Dose Study of PD-0360324 in Combination With Methotrexate in Patients With Rheumatoid Arthritis

Clinical trial NCT00550355 · COMPLETED

Trial details

NCT number
NCT00550355
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Arthritis, Rheumatoid
Start date
2007-08-01
Primary completion
2009-06-01
Enrollment
78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.